Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

NCT04308343 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04308343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04308343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Unknown status
Start date
March 30, 2020
Completion date
September 1, 2022
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ectopic pregnancy